Last close · 16 Oct 2026
Rs 128.65 -0.96%
Annual · FY2020 – FY2026
BF Biosciences Limited (BFBIO) cash flow statement
| Rs mn | FY2026 Jul 2025 – Jun 2026 | FY2025 Jul 2024 – Jun 2025 | FY2024 Jul 2023 – Jun 2024 | FY2023 Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 | ||
|---|---|---|---|---|---|---|---|
| Operating activities | |||||||
| Profit (cash-flow starting line, as reported) | — | 447.1 | 385.4 | 202.2 | 348.8 | ||
| Depreciation & amortisation | — | 193.6 | 36.1 | 34.3 | 28.3 | ||
| Net cash from operating activities | — | 282.6 | 519.5 | (232.9) | 292.0 | ||
| Investing activities | |||||||
| Capital expenditure | — | (329.5) | (143.1) | (1,970.0) | (1,130.2) | ||
| Net cash from investing activities | — | (1,430.1) | (30.1) | (807.8) | (1,602.0) | ||
| Financing activities | |||||||
| Borrowings raised / (repaid) | — | (342.6) | (321.4) | 760.5 | 950.6 | ||
| Net cash from financing activities | — | 1,512.6 | (321.4) | 760.5 | 950.6 | ||
| Net change in cash | — | 365.0 | 168.0 | (280.3) | (359.4) | ||
| Key figures | |||||||
| Free cash flow (operating cash flow − capex) | — | (46.9) | 376.4 | (2,203.0) | (838.1) | ||
| Rs mn | FY2026 Jul 2025 – Jun 2026 | FY2025 Jul 2024 – Jun 2025 | FY2024 Jul 2023 – Jun 2024 | FY2023 Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 | ||
|---|---|---|---|---|---|---|---|
| Operating activities | |||||||
| Profit (cash-flow starting line, as reported) | — | +16.0% | +90.6% | -42.0% | -46.0% | ||
| Depreciation & amortisation | — | +436.0% | +5.2% | +21.2% | +20.9% | ||
| Net cash from operating activities | — | -45.6% | — | -179.8% | -50.0% | ||
| Investing activities | |||||||
| Capital expenditure | — | +130.2% | -92.7% | +74.3% | +20.1% | ||
| Net cash from investing activities | — | — | — | — | — | ||
| Financing activities | |||||||
| Borrowings raised / (repaid) | — | — | -142.3% | -20.0% | -19.8% | ||
| Net cash from financing activities | — | — | -142.3% | -20.0% | -19.8% | ||
| Net change in cash | — | +117.3% | — | — | -191.5% | ||
| Key figures | |||||||
| Free cash flow (operating cash flow − capex) | — | -112.5% | — | — | — | ||
Change against the previous fiscal year; shown when the earlier figure is positive.
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets; "—" = not reported. Updated 16 Oct 2026.
All reported line items 51
| Rs mn | FY2026 Jul 2025 – Jun 2026 | FY2025 Jul 2024 – Jun 2025 | FY2024 Jul 2023 – Jun 2024 | FY2023 Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 |
|---|---|---|---|---|---|
| Profit/(Loss) - Starting Line - Cash Flow | — | 447.1 | 385.4 | 202.2 | 348.8 |
| Non-cash Items & Reconciliation Adjustments - Cash Flow | — | 486.9 | 390.7 | 96.2 | (69.6) |
| Income Tax Expense - Cash Flow - to Reconcile | — | 273.4 | 190.2 | — | — |
| Other Non-Cash Items & Reconciliation Adjustments - Cash Flow - to Reconcile | — | 21.0 | 36.2 | 4.9 | (19.4) |
| Financial Income/(Expense) - Cash Flow - to Reconcile | — | 29.0 | 130.5 | 66.9 | (73.4) |
| Depreciation, Depletion & Amortization including Impairment - Cash Flow - to Reconcile | — | 193.6 | 36.1 | 34.3 | 28.3 |
| Depreciation & Depletion - Property, Plant & Equipment - Cash Flow - to Reconcile | — | 191.9 | 35.6 | 33.8 | 28.3 |
| Amortization - Intangible Assets & Deferred Charges - Cash Flow - to Reconcile | — | 1.7 | 0.6 | 0.6 | — |
| Assets Sale - Gain/(Loss) - Cash Flow - to Reconcile | — | (27.8) | (2.4) | (9.0) | (3.3) |
| Financial Assets - Unrealized Gain/(Loss) - Cash Flow - to Reconcile | — | (2.3) | 0.1 | (1.0) | (1.8) |
| Income Taxes - Paid/(Reimbursed) - Cash Flow | — | 279.1 | 51.4 | 92.8 | 60.0 |
| Interest Paid - Cash | — | 112.2 | 161.5 | 120.3 | 25.1 |
| Interest & Dividends - Received - Total - Cash Flow | — | 95.0 | 19.3 | 83.4 | 139.0 |
| Cash Flow from Operating Activities before Changes in Working Capital | — | 637.8 | 582.5 | 168.6 | 333.1 |
| Working Capital - Increase/(Decrease) - Cash Flow | — | (355.2) | (63.0) | (401.6) | (41.1) |
| Accounts Receivables - Decrease/(Increase) - Cash Flow | — | (50.5) | (122.7) | (40.1) | 161.7 |
| Inventories - Decrease/(Increase) - Cash Flow | — | (846.4) | (41.6) | (445.7) | (50.4) |
| Other Assets - Decrease/(Increase) - Cash Flow | — | 74.6 | (115.2) | 108.0 | (175.8) |
| Accounts Payable and Accrued Expenses - Increase/(Decrease) - Cash Flow | — | 472.4 | 196.8 | (5.9) | 12.5 |
| Other Liabilities - Increase/(Decrease) -Total - Cash Flow | — | (5.3) | 19.7 | (17.8) | 10.9 |
| Net Cash Flow from Operating Activities | — | 282.6 | 519.5 | (232.9) | 292.0 |
| Capital Expenditures - Net - Cash Flow | — | 325.6 | 138.7 | 1,969.0 | 1,125.9 |
| Property, Plant & Equipment - Purchased/(Sold) - Net - Cash Flow | — | 325.6 | 138.7 | 1,967.3 | 1,125.9 |
| Property, Plant & Equipment - Purchased - Cash Flow | — | 329.5 | 143.1 | 1,968.4 | 1,130.2 |
| Property, Plant & Equipment Sold - Cash Flow | — | 3.9 | 4.4 | 1.1 | 4.3 |
| Intangible Assets - Purchased/(Sold) - Net - Total - Cash Flow | — | — | 0.0 | 1.7 | — |
| Intangible Assets - Purchased/Acquired - Cash Flow | — | — | 0.0 | 1.7 | — |
| Capital Expenditures - Total | — | 329.5 | 143.1 | 1,970.0 | 1,130.2 |
| Investments excluding Loans - Decrease/(Increase) - Cash Flow | — | (1,100.4) | 108.6 | 1,161.1 | (476.1) |
| Investment Securities - Unclassified - Sold/(Purchased) - Net - Total - Cash Flow | — | (1,100.4) | 108.6 | 1,161.1 | (476.1) |
| Other Investing Cash Flow - Decrease/(Increase) | — | (4.0) | — | — | 0.0 |
| Net Cash Flow from Investing Activities | — | (1,430.1) | (30.1) | (807.8) | (1,602.0) |
| Debt - Long-Term & Short-Term - Issuance/(Retirement) - Total - Cash Flow | — | (342.6) | (321.4) | 760.5 | 950.6 |
| Debt - Issued/Reduced - Long-Term - Cash Flow | — | (342.6) | (321.4) | 760.5 | 950.6 |
| Debt - Issued - Long-Term - Cash Flow | — | 93.6 | 0.0 | 811.0 | 968.1 |
| Debt - Reduced - Long-Term - Cash Flow | — | 436.2 | 321.4 | 50.5 | 17.5 |
| Other Financing Cash Flow - Increase/(Decrease) | — | 1,855.2 | — | — | — |
| Net Cash Flow from Financing Activities | — | 1,512.6 | (321.4) | 760.5 | 950.6 |
| Net Change in Cash - Total | — | 365.0 | 168.0 | (280.3) | (359.4) |
| Net Cash from Continuing Operations | — | 365.0 | 168.0 | (280.3) | (359.4) |
| Net Cash - Beginning Balance | — | (49.9) | (217.9) | 62.3 | 421.7 |
| Net Cash - Ending Balance | — | 315.1 | (49.9) | (217.9) | 62.3 |
| Income Taxes - Paid/(Reimbursed) - Cash Flow - Supplemental | — | 279.1 | 51.4 | 92.8 | 60.0 |
| Interest Paid - Cash Flow - Supplemental | — | 112.2 | 161.5 | 120.3 | 25.1 |
| Interest & Dividends - Received - Cash Flow - Supplemental | — | 95.0 | 19.3 | 83.4 | 139.0 |
| CF from Optg Activities before Change in WC & Int Payments | — | 750.0 | 744.0 | 288.9 | 358.2 |
| Contract Liabilities - Increase/(Decrease) - Cash Flow | — | (5.3) | 19.7 | (17.8) | 10.9 |
| Depreciation, Depletion & Amortization - Cash Flow | — | 193.6 | 36.1 | 34.3 | 28.3 |
| Free Cash Flow to Equity | — | (385.7) | 59.4 | (1,441.4) | 116.7 |
| Free Cash Flow Net of Dividends | — | (46.9) | 376.4 | (2,203.0) | (838.1) |
| Free Cash Flow | — | (46.9) | 376.4 | (2,203.0) | (838.1) |
Every line the company reported, in the original order and wording, without regrouping or signs changed.